Medication info
Sitaren 50 mg (Sitagliptin Hydrochloride Hydrate)

Sitaren 50 mg (Sitagliptin Hydrochloride Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Sitagliptin Hydrochloride Hydrate›56.7mg / 1 tablet
Manufacturer / importer
NexPharm Korea Co., Ltd.
Appearance
Light yellow-pink, round, biconvex film-coated tablets
Packaging
30 tablets/box [(10 tablets/PTP x 3)]
Approval status
Active

MFDS item code 202005702 · Approved 2020.08.07 · Insurance code 662504570

Summary

Main use
Improvement of blood glucose control in type 2 diabetes
Who takes it
Adults
Adult dose
This medicine is administered at 100 mg once daily as monotherapy or in combination therapy, with a maximum daily dose of 100 mg. This medicine may be taken with or without food. When administered concomitantly with a sulfonylurea or insulin, consider reducing the dose of the sulfonylurea or insulin to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for use, 5. General precautions). Patients with renal impairment Since dose adjustment according to renal function is required, evaluation of renal function is recommended before administration of this medicine and periodically thereafter. 1. No dose adjustment is required in patients with mild renal impairment (glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is required in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily in patients with severe renal impairment (glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered without regard to the timing of dialysis.

Ingredients

Manufacturer
NexPharm Korea Co., Ltd.

Efficacy & effects

Improvement of blood glucose control in type 2 diabetes

  • Difficulty in blood sugar control in patients with type 2 diabetes
View approved original text

This medication is used as an adjunct to diet and exercise to improve blood sugar control in patients with type 2 diabetes. It can be administered as monotherapy, and in cases where sufficient blood sugar control is difficult with monotherapy for patients who have not previously received antidiabetic drug treatment, it may be used in combination with metformin. Additionally, it can be combined with sulfonylureas, metformin, thiazolidinediones, or insulin in cases where blood glucose control is not sufficient through monotherapy. Furthermore, for patients who find blood glucose control challenging with multiple drug regimens, adding this medication can lead to further improved blood sugar control. Thus, this medication can be effectively utilized in various situations to aid in blood sugar control and diabetes treatment.

How to take

Adult dose

This medicine is administered at 100 mg once daily as monotherapy or in combination therapy, with a maximum daily dose of 100 mg. This medicine may be taken with or without food. When administered concomitantly with a sulfonylurea or insulin, consider reducing the dose of the sulfonylurea or insulin to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for use, 5. General precautions). Patients with renal impairment Since dose adjustment according to renal function is required, evaluation of renal function is recommended before administration of this medicine and periodically thereafter. 1. No dose adjustment is required in patients with mild renal impairment (glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is required in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily in patients with severe renal impairment (glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered without regard to the timing of dialysis.

Precautions

This medication is used for diabetes treatment, and there are several precautions to observe when taking it. First, there is a possibility of a rare severe allergic reaction while taking this medication; if symptoms such as skin rash, difficulty breathing, or swelling of the face or neck occur, immediately discontinue use and consult a physician. Second, this medication may cause a serious side effect known as pancreatitis, which is inflammation of the pancreas; therefore, if there is abdominal pain, vomiting, or severe abdominal discomfort, it is essential to notify healthcare personnel immediately. Third, this medication should not be taken by patients with type 1 diabetes, diabetic ketoacidosis, or those who have hypersensitivity to this medication or its components. Fourth, patients with impaired kidney function should have their dosage adjusted, and kidney function tests should be performed before and during the medication. Fifth, when taken with sulfonylureas or insulin, there may be an increased risk of hypoglycemia, so patients should be vigilant for symptoms of low blood sugar and check their blood glucose frequently if necessary. Sixth, severe joint pain or blistering skin diseases may occur during treatment with this medication, and if these symptoms appear, it is crucial to inform a physician immediately and consider discontinuation of the medication. Seventh, it is not recommended for pregnant or breastfeeding women, and safety has not been confirmed for children under 18 years of age. Finally, in case of overdose, it is essential to visit a medical institution for appropriate treatment and monitoring, as some of the medication may be removed through hemodialysis. During the use of this medication, it is crucial to consult healthcare personnel if any of the above symptoms or abnormalities occur in order to receive appropriate measures.

Side effects

  • Severe hypersensitivity reactions
  • anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • exfoliative dermatitis
  • acute pancreatitis
  • hypoglycemia
  • upper respiratory infections
  • nasopharyngitis
  • headache
Show 30 more
  • diarrhea
  • abdominal pain
  • nausea
  • constipation
  • vomiting
  • severe and disabling arthralgia
  • vesicular pemphigoid
  • myalgia
  • limb pain
  • back pain
  • interstitial lung disease
  • pruritus
  • thrombocytopenia
  • rhabdomyolysis
  • elevated liver enzymes
  • acute renal failure
  • pneumonia
  • diabetes complications
  • metabolic acidosis
  • falls
  • cardiac arrest
  • dyspepsia
  • dizziness
  • increased blood triglycerides
  • gastritis
  • severe hypoglycemia
  • weight loss
  • hypertension
  • hypernatremia
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air exposure, and it is advisable to keep it at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness and prevent degradation.

Appearance and packaging

Appearance

Light yellow-pink, round, biconvex film-coated tablets

Package unit

30 tablets/box [(10 tablets/PTP x 3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.